Who Buys Topotecan from India — 113 Importers Behind a $3.8M Market
India's topotecan import market is served by 113 active buyers who collectively imported $3.8M across 558 shipments. ACCORD HEALTHCARE POLSKA SP. Z O.O. (POLAND) leads with a 15.7% market share, followed by EVERSANA LIFE SCIENCES SERVICES,LLC and ACCORD FARMACUTICA LTDA. The top 5 buyers together control 47.1% of total import value, reflecting a moderately competitive buyer landscape.
Top Topotecan Importers — Ranked by Import Value
ACCORD HEALTHCARE POLSKA SP. Z O.O. (POLAND) is the leading topotecan importer from India, holding a 15.7% share of the $3.8M market across 558 shipments from 113 buyers. The top 5 buyers — ACCORD HEALTHCARE POLSKA SP. Z O.O. (POLAND), EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), ACCORD FARMACUTICA LTDA (BRAZIL), ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND), ALLOGA FRANCE (NETHERLANDS) — collectively control 47.1% of total import value.
Top Topotecan Buyers & Importers
Ranked by import value · 113 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | ACCORD HEALTHCARE POLSKA SP. Z O.O.POLAND PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4MLPHARMA DRUGS & MEDI TOPOTECAN HCL FOR IN | $589.6K | 5 | 15.7% |
| 2 | EVERSANA LIFE SCIENCES SERVICES,LLCUNITED STATES | $465.3K | 5 | 12.4% |
| 3 | ACCORD FARMACUTICA LTDABRAZIL PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4MLPHARMA DRUGS & MEDI TOPOTECAN HCL FOR IN | $257.0K | 5 | 6.8% |
| 4 | ACCORD HEALTHCARE POLSKA SP. Z.O.O.POLAND PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4MLPHARMA DRUGS & MEDI TOPOTECAN HCL FOR IN | $236.9K | 5 | 6.3% |
| 5 | ALLOGA FRANCENETHERLANDS PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML, | $220.8K | 5 | 5.9% |
| 6 | ACCORD FARMACUTICA LTDA.BRAZIL PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4MLPHARMA DRUGS & MEDI TOPOTECAN HCL FOR IN | $170.1K | 5 | 4.5% |
| 7 | BROCACEF NL : HUBNETHERLANDS PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML, | $112.4K | 5 | 3.0% |
| 8 | ACCORD HEALTHCARE, SLUSPAIN PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4MLPHARMA DRUGS & MEDI TOPOTECAN HCL FOR IN | $82.1K | 5 | 2.2% |
| 9 | ACCORD HEALTHCARE ITALIA SRLITALY PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4MLPHARMA DRUGS & MEDI TOPOTECAN HCL FOR IN | $70.6K | 5 | 1.9% |
| 10 | EVERSANA LIFE SCIENCES SERVICES LLCUNITED STATES | $70.2K | 5 | 1.9% |
| 11 | BROCACEF NL:EU HUBNETHERLANDS PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML, | $70.0K | 5 | 1.9% |
| 12 | M/S. SUN PHARMACEUTICALS MOROCCO LLMOROCCO TOPOTECAN SUN INJ 4MG HOSPITAL PACK:1 VI | $62.4K | 5 | 1.7% |
| 13 | E P H KHUNGARY PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4MLPHARMA DRUGS & MEDI TOPOTECAN HCL FOR IN | $59.2K | 5 | 1.6% |
| 14 | HB HUMAN BIOSCIENCE S.A.SCOLOMBIA TOPOTECAN FOR INJECTION 4.0 MG EACH VIALTOPOTECAN FOR INJ.4.0 MG E.VL.C.TOPOTECA | $54.9K | 5 | 1.5% |
| 15 | ACCORD HEALTHCARE POLSKA SP. Z O.OPOLAND PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4MLPHARMA DRUGS & MEDI TOPOTECAN HCL FOR IN | $52.5K | 5 | 1.4% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Topotecan — and from which countries?
Flow of Topotecan exports from India: each country's share and the named importers behind the numbers
Topotecan — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Poland
Poland emerges as the first largest importing country, achieving a total trade value of $1.1M through 50 shipments. This represents a market share of 29.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Poland has a diverse importer base, with their top importers including:
• ACCORD HEALTHCARE POLSKA SP. Z O.O. - $589.6K (52.7% of country's total business)
• ACCORD HEALTHCARE POLSKA SP. Z.O.O. - $236.9K (21.2% of country's total business)
• ACCORD HEALTHCARE POLSKA SP. Z O.O - $52.5K (4.7% of country's total business)
• ACCORD HEALTHCARE POLSKA SP Z O O - $44.7K (4.0% of country's total business)
Key Insight: Poland demonstrates strong market positioning with an average shipment value of $22.4K, indicating premium pricing strategy compared to the market average of $6.7K.
Poland is a key market for Topotecan imports, representing 29.8% of total trade value.
2Netherlands
Netherlands emerges as the second largest importing country, achieving a total trade value of $589.3K through 51 shipments. This represents a market share of 15.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• ALLOGA FRANCE - $220.8K (37.5% of country's total business)
• BROCACEF NL : HUB - $112.4K (19.1% of country's total business)
• BROCACEF NL:EU HUB - $70.0K (11.9% of country's total business)
• BROCACEF NL HUB - $42.7K (7.2% of country's total business)
• BROCACEF NL HUB BROCACEF HEALTHCAR - $38.9K (6.6% of country's total business)
• Rest of Netherlands's importers - $104.4K (17.7% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $11.6K, indicating premium pricing strategy compared to the market average of $6.7K.
Netherlands is a key market for Topotecan imports, representing 15.7% of total trade value.
3United States
United States emerges as the third largest importing country, achieving a total trade value of $559.7K through 18 shipments. This represents a market share of 14.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCES SERVICES,LLC - $465.3K (83.1% of country's total business)
• EVERSANA LIFE SCIENCES SERVICES LLC - $70.2K (12.5% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $31.1K, indicating premium pricing strategy compared to the market average of $6.7K.
United States is a key market for Topotecan imports, representing 14.9% of total trade value.
4Brazil
Brazil emerges as the fourth largest importing country, achieving a total trade value of $515.8K through 6 shipments. This represents a market share of 13.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• ACCORD FARMACUTICA LTDA - $257.0K (49.8% of country's total business)
• ACCORD FARMACUTICA LTDA. - $170.1K (33.0% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $86.0K, indicating premium pricing strategy compared to the market average of $6.7K.
Brazil is a key market for Topotecan imports, representing 13.7% of total trade value.
5Morocco
Morocco emerges as the fifth largest importing country, achieving a total trade value of $111.1K through 2 shipments. This represents a market share of 3.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Morocco has a diverse importer base, with their top importers including:
• M/S. SUN PHARMACEUTICALS MOROCCO LL - $62.4K (56.2% of country's total business)
Key Insight: Morocco demonstrates strong market positioning with an average shipment value of $55.5K, indicating premium pricing strategy compared to the market average of $6.7K.
Morocco is a key market for Topotecan imports, representing 3.0% of total trade value.
Buyer Segment Analysis
TransData Nexus Topotecan buyer market intelligence
1Buyer Segment Analysis
The importation of Topotecan from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like EVERSANA LIFE SCIENCES SERVICES, LLC (United States) and BROCACEF NL: HUB (Netherlands) function as intermediaries, procuring Topotecan in bulk to supply to healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
- Hospital Groups: Organizations such as ACCORD HEALTHCARE POLSKA SP. Z O.O. (Poland) and ACCORD HEALTHCARE ITALIA SRL (Italy) represent hospital networks that import Topotecan directly for patient treatment. Their procurement is driven by patient demand and treatment protocols, leading to consistent, scheduled orders.
- Re-exporters: Companies like ALLOGA FRANCE (Netherlands) may act as re-exporters, importing Topotecan for redistribution to other markets. Their purchasing behavior is influenced by international demand and trade agreements, resulting in variable order sizes and frequencies.
Each segment's procurement strategies are tailored to their operational needs, ensuring the availability of Topotecan for therapeutic use.
Country-Specific Import Regulations
TransData Nexus Topotecan buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Topotecan in the top importing countries is crucial:
- Poland:
- Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
- Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
- Estimated Timeline: Approximately 210 days for standard procedures.
- Import Tariff/Duty: As an EU member, Poland applies a 0% tariff on pharmaceutical products under HS Code 30049049.
- Netherlands:
- Regulatory Authority: Medicines Evaluation Board (MEB).
- Import Registration Process: Involves obtaining a marketing authorization, necessitating comprehensive documentation on the product.
- Estimated Timeline: Around 210 days, aligning with EU standards.
- Import Tariff/Duty: 0% tariff for pharmaceuticals under HS Code 30049049, consistent with EU regulations.
- United States:
- Regulatory Authority: U.S. Food and Drug Administration (FDA).
- Import Registration Process: Requires an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), including clinical trial data.
- Estimated Timeline: Varies; standard NDA reviews take approximately 10 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are typically duty-free.
- Brazil:
- Regulatory Authority: National Health Surveillance Agency (ANVISA).
- Import Registration Process: Involves submission of a registration dossier with quality, safety, and efficacy information.
- Estimated Timeline: Approximately 365 days, subject to ANVISA's review process.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are subject to a 14% import duty.
- Morocco:
- Regulatory Authority: Directorate of Medicines and Pharmacy (DMP).
- Import Registration Process: Requires a marketing authorization application, including detailed product information.
- Estimated Timeline: Approximately 180 days, depending on dossier completeness.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are subject to a 2.5% import duty.
Compliance with these regulations ensures the legal and efficient importation of Topotecan into these markets.
Demand Drivers & Market Opportunity
TransData Nexus Topotecan buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Topotecan in importing countries is influenced by several factors:
- Disease Prevalence: Topotecan is primarily used in the treatment of certain cancers, including ovarian and small cell lung cancer. The incidence rates of these cancers in importing countries directly impact demand.
- Government Healthcare Programs: Initiatives aimed at improving cancer care, such as national cancer control programs, increase the accessibility and affordability of treatments like Topotecan.
- Universal Health Coverage Expansion: Countries expanding health coverage ensure a larger population has access to essential medicines, boosting demand.
- WHO Essential Medicines List Procurement: Inclusion of Topotecan in the WHO Essential Medicines List encourages its procurement by health systems, aligning with global health priorities.
- Tender-Based Purchasing: Many countries utilize tendering processes for pharmaceutical procurement, promoting competitive pricing and consistent supply.
With 113 buyers across 51 countries, the market for Topotecan is substantial. Understanding these demand drivers enables stakeholders to identify and capitalize on market opportunities effectively.
Common Questions — Topotecan Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest topotecan buyer importing from India?
Based on import volume and value, ACCORD HEALTHCARE POLSKA SP. Z O.O. (POLAND) leads with $589.6K in imports and a 15.7% market share — the highest of any single topotecan importer. EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) and ACCORD FARMACUTICA LTDA (BRAZIL) are the next largest buyers.
QHow many companies buy topotecan from India?
There are 113 active topotecan buyers importing from India, with a combined market of $3.8M across 558 shipments to 51 countries. The top 5 buyers hold 47.1% of total import value, while the remaining 108 buyers handle the other 52.9%.
QWhich countries import the most topotecan from India?
The top importing countries for topotecan from India are Poland (29.8%), Netherlands (15.7%), United States (14.9%), Brazil (13.7%), Morocco (3.0%). These markets represent the largest demand centres for Indian pharmaceutical exports of topotecan, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for topotecan from India?
The average import transaction value for topotecan from India is $6.7K, with an average unit price of $12.87 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Topotecan buyer market intelligence
1Buyer Segment Analysis
The importation of Topotecan from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like EVERSANA LIFE SCIENCES SERVICES, LLC (United States) and BROCACEF NL: HUB (Netherlands) function as intermediaries, procuring Topotecan in bulk to supply to healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
- Hospital Groups: Organizations such as ACCORD HEALTHCARE POLSKA SP. Z O.O. (Poland) and ACCORD HEALTHCARE ITALIA SRL (Italy) represent hospital networks that import Topotecan directly for patient treatment. Their procurement is driven by patient demand and treatment protocols, leading to consistent, scheduled orders.
- Re-exporters: Companies like ALLOGA FRANCE (Netherlands) may act as re-exporters, importing Topotecan for redistribution to other markets. Their purchasing behavior is influenced by international demand and trade agreements, resulting in variable order sizes and frequencies.
Each segment's procurement strategies are tailored to their operational needs, ensuring the availability of Topotecan for therapeutic use.
Country-Specific Import Regulations
TransData Nexus Topotecan buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Topotecan in the top importing countries is crucial:
- Poland:
- Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
- Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
- Estimated Timeline: Approximately 210 days for standard procedures.
- Import Tariff/Duty: As an EU member, Poland applies a 0% tariff on pharmaceutical products under HS Code 30049049.
- Netherlands:
- Regulatory Authority: Medicines Evaluation Board (MEB).
- Import Registration Process: Involves obtaining a marketing authorization, necessitating comprehensive documentation on the product.
- Estimated Timeline: Around 210 days, aligning with EU standards.
- Import Tariff/Duty: 0% tariff for pharmaceuticals under HS Code 30049049, consistent with EU regulations.
- United States:
- Regulatory Authority: U.S. Food and Drug Administration (FDA).
- Import Registration Process: Requires an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), including clinical trial data.
- Estimated Timeline: Varies; standard NDA reviews take approximately 10 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are typically duty-free.
- Brazil:
- Regulatory Authority: National Health Surveillance Agency (ANVISA).
- Import Registration Process: Involves submission of a registration dossier with quality, safety, and efficacy information.
- Estimated Timeline: Approximately 365 days, subject to ANVISA's review process.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are subject to a 14% import duty.
- Morocco:
- Regulatory Authority: Directorate of Medicines and Pharmacy (DMP).
- Import Registration Process: Requires a marketing authorization application, including detailed product information.
- Estimated Timeline: Approximately 180 days, depending on dossier completeness.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049049 are subject to a 2.5% import duty.
Compliance with these regulations ensures the legal and efficient importation of Topotecan into these markets.
Demand Drivers & Market Opportunity
TransData Nexus Topotecan buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Topotecan in importing countries is influenced by several factors:
- Disease Prevalence: Topotecan is primarily used in the treatment of certain cancers, including ovarian and small cell lung cancer. The incidence rates of these cancers in importing countries directly impact demand.
- Government Healthcare Programs: Initiatives aimed at improving cancer care, such as national cancer control programs, increase the accessibility and affordability of treatments like Topotecan.
- Universal Health Coverage Expansion: Countries expanding health coverage ensure a larger population has access to essential medicines, boosting demand.
- WHO Essential Medicines List Procurement: Inclusion of Topotecan in the WHO Essential Medicines List encourages its procurement by health systems, aligning with global health priorities.
- Tender-Based Purchasing: Many countries utilize tendering processes for pharmaceutical procurement, promoting competitive pricing and consistent supply.
With 113 buyers across 51 countries, the market for Topotecan is substantial. Understanding these demand drivers enables stakeholders to identify and capitalize on market opportunities effectively.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 113 global importers of Topotecan identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 558 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 51 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
558 Verified Shipments
113 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists